{"count":30,"next":"https://lda.gov/api/v1/filings/?filing_specific_lobbying_issues=S.+3794&filing_year=2026&ordering=-filing_year&page=2","previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/8d978aeb-7e2e-4ace-9825-ec277b70776f/","filing_uuid":"8d978aeb-7e2e-4ace-9825-ec277b70776f","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/8d978aeb-7e2e-4ace-9825-ec277b70776f/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Megan Herber","dt_posted":"2026-04-16T13:32:02-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1500 K St NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":12631,"url":"https://lda.gov/api/v1/registrants/12631/","house_registrant_id":31801,"name":"FAEGRE DRINKER BIDDLE & REATH LLP","description":"Law firm","address_1":"1500 K St NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ZOOK","contact_telephone":"+1 202-312-7414","dt_updated":"2026-07-30T11:30:36.878220-04:00"},"client":{"id":204140,"url":"https://lda.gov/api/v1/clients/204140/","client_id":1006361,"name":"NATIONAL ASSOCIATION OF BOARDS OF PHARMACY","general_description":"Association of member boards of pharmacy to protect public health","client_government_entity":false,"client_self_select":null,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":79283,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":"SUSSMAN","last_name":"HERBER","suffix":null,"suffix_display":null},"covered_position":"Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA)","new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009-2010","new":false},{"lobbyist":{"id":143298,"prefix":null,"prefix_display":null,"first_name":"MAYA","nickname":null,"middle_name":null,"last_name":"BOLTER","suffix":null,"suffix_display":null},"covered_position":"Legislative Intern, Representative Dean Phillips (D-MN-03), September 2019-December 2019","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":79283,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":"SUSSMAN","last_name":"HERBER","suffix":null,"suffix_display":null},"covered_position":"Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA)","new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009-2010","new":false},{"lobbyist":{"id":143298,"prefix":null,"prefix_display":null,"first_name":"MAYA","nickname":null,"middle_name":null,"last_name":"BOLTER","suffix":null,"suffix_display":null},"covered_position":"Legislative Intern, Representative Dean Phillips (D-MN-03), September 2010-December 2019","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/71566a80-02a3-4e90-a3ad-bc0e54fbb422/","filing_uuid":"71566a80-02a3-4e90-a3ad-bc0e54fbb422","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/71566a80-02a3-4e90-a3ad-bc0e54fbb422/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Elizabeth Baney","dt_posted":"2026-04-17T17:15:59-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1500 K Street NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":12631,"url":"https://lda.gov/api/v1/registrants/12631/","house_registrant_id":31801,"name":"FAEGRE DRINKER BIDDLE & REATH LLP","description":"Law firm","address_1":"1500 K St NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ZOOK","contact_telephone":"+1 202-312-7414","dt_updated":"2026-07-30T11:30:36.878220-04:00"},"client":{"id":204137,"url":"https://lda.gov/api/v1/clients/204137/","client_id":1006373,"name":"ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL)","general_description":"Coalition to ensure patient access to safe and legitimate online pharmacies","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/71566a80-02a3-4e90-a3ad-bc0e54fbb422/","filing_uuid":"71566a80-02a3-4e90-a3ad-bc0e54fbb422","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/71566a80-02a3-4e90-a3ad-bc0e54fbb422/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Elizabeth Baney","dt_posted":"2026-04-17T17:15:59-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1500 K Street NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":12631,"url":"https://lda.gov/api/v1/registrants/12631/","house_registrant_id":31801,"name":"FAEGRE DRINKER BIDDLE & REATH LLP","description":"Law firm","address_1":"1500 K St NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ZOOK","contact_telephone":"+1 202-312-7414","dt_updated":"2026-07-30T11:30:36.878220-04:00"},"client":{"id":204137,"url":"https://lda.gov/api/v1/clients/204137/","client_id":1006373,"name":"ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL)","general_description":"Coalition to ensure patient access to safe and legitimate online pharmacies","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/71566a80-02a3-4e90-a3ad-bc0e54fbb422/","filing_uuid":"71566a80-02a3-4e90-a3ad-bc0e54fbb422","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/71566a80-02a3-4e90-a3ad-bc0e54fbb422/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Elizabeth Baney","dt_posted":"2026-04-17T17:15:59-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1500 K Street NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":12631,"url":"https://lda.gov/api/v1/registrants/12631/","house_registrant_id":31801,"name":"FAEGRE DRINKER BIDDLE & REATH LLP","description":"Law firm","address_1":"1500 K St NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ZOOK","contact_telephone":"+1 202-312-7414","dt_updated":"2026-07-30T11:30:36.878220-04:00"},"client":{"id":204137,"url":"https://lda.gov/api/v1/clients/204137/","client_id":1006373,"name":"ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL)","general_description":"Coalition to ensure patient access to safe and legitimate online pharmacies","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/71566a80-02a3-4e90-a3ad-bc0e54fbb422/","filing_uuid":"71566a80-02a3-4e90-a3ad-bc0e54fbb422","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/71566a80-02a3-4e90-a3ad-bc0e54fbb422/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Elizabeth Baney","dt_posted":"2026-04-17T17:15:59-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1500 K Street NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":12631,"url":"https://lda.gov/api/v1/registrants/12631/","house_registrant_id":31801,"name":"FAEGRE DRINKER BIDDLE & REATH LLP","description":"Law firm","address_1":"1500 K St NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ZOOK","contact_telephone":"+1 202-312-7414","dt_updated":"2026-07-30T11:30:36.878220-04:00"},"client":{"id":204137,"url":"https://lda.gov/api/v1/clients/204137/","client_id":1006373,"name":"ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL)","general_description":"Coalition to ensure patient access to safe and legitimate online pharmacies","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/cc3e52ae-261e-4862-96a8-b051c747fd25/","filing_uuid":"cc3e52ae-261e-4862-96a8-b051c747fd25","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/cc3e52ae-261e-4862-96a8-b051c747fd25/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Zachary Williams","dt_posted":"2026-04-18T15:10:11-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"777 6th Street NW","registrant_address_2":"8th Floor","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":400976792,"url":"https://lda.gov/api/v1/registrants/400976792/","house_registrant_id":null,"name":"FORBES-TATE","description":"Government Relations Firm.","address_1":"777 6th Street NW","address_2":"8th Floor","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ZACHARY WILLIAMS","contact_telephone":"+1 202-638-0125","dt_updated":"2026-07-20T16:54:02.529740-04:00"},"client":{"id":205133,"url":"https://lda.gov/api/v1/clients/205133/","client_id":1573,"name":"ELI LILLY AND COMPANY FKA LILLY USA, LLC","general_description":"Pharmaceutical Company","client_government_entity":false,"client_self_select":null,"state":"IN","state_display":"Indiana","country":"US","country_display":"United States of America","ppb_state":"IN","ppb_state_display":"Indiana","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to the report accompanying the FY 26 Senate Labor-HHS-Education Appropriations; Issues related to Rx drug pricing in the One Big Beautiful Bill Act (P.L. 119-21).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/cc3e52ae-261e-4862-96a8-b051c747fd25/","filing_uuid":"cc3e52ae-261e-4862-96a8-b051c747fd25","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/cc3e52ae-261e-4862-96a8-b051c747fd25/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Zachary Williams","dt_posted":"2026-04-18T15:10:11-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"777 6th Street NW","registrant_address_2":"8th Floor","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":400976792,"url":"https://lda.gov/api/v1/registrants/400976792/","house_registrant_id":null,"name":"FORBES-TATE","description":"Government Relations Firm.","address_1":"777 6th Street NW","address_2":"8th Floor","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ZACHARY WILLIAMS","contact_telephone":"+1 202-638-0125","dt_updated":"2026-07-20T16:54:02.529740-04:00"},"client":{"id":205133,"url":"https://lda.gov/api/v1/clients/205133/","client_id":1573,"name":"ELI LILLY AND COMPANY FKA LILLY USA, LLC","general_description":"Pharmaceutical Company","client_government_entity":false,"client_self_select":null,"state":"IN","state_display":"Indiana","country":"US","country_display":"United States of America","ppb_state":"IN","ppb_state_display":"Indiana","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to the report accompanying the FY 26 Senate Labor-HHS-Education Appropriations; Issues related to Rx drug pricing in the One Big Beautiful Bill Act (P.L. 119-21).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d382efdf-4f13-4d42-a2e9-8e476aa54f45/","filing_uuid":"d382efdf-4f13-4d42-a2e9-8e476aa54f45","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/d382efdf-4f13-4d42-a2e9-8e476aa54f45/print/","filing_document_content_type":"text/html","income":null,"expenses":"220000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Amy Shank","dt_posted":"2026-04-20T12:22:15-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"9901 S. Wilcrest Dr","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Houston","registrant_state":"TX","registrant_zip":"77099","registrant":{"id":401103386,"url":"https://lda.gov/api/v1/registrants/401103386/","house_registrant_id":null,"name":"PROFESSIONAL COMPOUNDING CENTERS OF AMERICA","description":"Membership organization providing resources to independent compounding pharmacies","address_1":"9901 S. Wilcrest Dr","address_2":null,"address_3":null,"address_4":null,"city":"Houston","state":"TX","state_display":"Texas","zip":"77099","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"AMY SHANK","contact_telephone":"+1 202-412-0412","dt_updated":"2026-07-24T14:07:59.280567-04:00"},"client":{"id":198794,"url":"https://lda.gov/api/v1/clients/198794/","client_id":12,"name":"PROFESSIONAL COMPOUNDING CENTERS OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-07-21"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to implementation of the Drug Quality and Security Act, issues related to animal drug compounding, issues relating to opioid safety; issues related to the pharmaceutical supply chain; issues related to drug shortages; H.R. 5316, the Drug Shortage Compounding Patient Access Act of 2025; S. 3794 / H.R. 6509, The Safe Drugs Act; S. 3788, The Clear Labels Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60863,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"SHANK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to Medicare coverage of compounded medications, Drug shortages and Medicare reimbursement for compounded medications, pharmacy direct and indirect remuneration fees","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60863,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"SHANK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Agriculture appropriations spending bill; Department of Labor-Health and Human Services appropriations bill","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60863,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"SHANK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e43e783b-7f1d-4858-97b6-d753c499d8f6/","filing_uuid":"e43e783b-7f1d-4858-97b6-d753c499d8f6","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/e43e783b-7f1d-4858-97b6-d753c499d8f6/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Mark Kinney","dt_posted":"2026-07-14T12:52:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1550 Columbus Street","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Sun Prairie","registrant_state":"WI","registrant_zip":"53590","registrant":{"id":313098,"url":"https://lda.gov/api/v1/registrants/313098/","house_registrant_id":39121,"name":"INDEPENDENT PHARMACY COOPERATIVE","description":null,"address_1":"1550 Columbus Street","address_2":null,"address_3":null,"address_4":null,"city":"Sun Prairie","state":"WI","state_display":"Wisconsin","zip":"53590","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MR. MARK KINNEY","contact_telephone":"+1 608-628-7311","dt_updated":"2026-07-14T13:14:46.836994-04:00"},"client":{"id":184073,"url":"https://lda.gov/api/v1/clients/184073/","client_id":12,"name":"INDEPENDENT PHARMACY COOPERATIVE","general_description":"National GPO and drug distribution services for independent pharmacies.","client_government_entity":false,"client_self_select":true,"state":"WI","state_display":"Wisconsin","country":"US","country_display":"United States of America","ppb_state":"WI","ppb_state_display":"Wisconsin","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-07-16"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"IPC supports S. 526 Pharmacy Benefit Manager Transparency Act of 2025 IPC supports S. 527 \"Prescription Pricing for People Act of 2025 IPC supports S. 882 Patients Before Middlemen Act IPC supports H.R. 4317/S.3345 PBM Reform Act of 2025 IPC supports H.R. 3164/S. 2426 - \"Main Street Pharmacy Access Act\" IPC supports H.R. 6609 & H.R. 6610 - Pharmacists Fights Back Act IPC supports H.R. 5256 340B Affording Care for Communities and Ensuring a Strong Safety-Net Act (340B ACCESS Act) CMS Plan Year 2027 Medicare Drug Price Negotiation Program list of negotiated drug prices and process for negotiations. IPC monitors Trump Administration 340B Rebate Pilot Program adoption and implementation IPC supports OBBBA - Rural Health Transformation Program - grant implementation IPC monitors Senate BI-Partisan 340B working group - draft legislation IPC monitors Trump Administration overseas manufactured drug Section 232 tariffs investigation IPC monitors Trump Administration Drug Pricing Most Favored Nations status/Direct to Consumer (DTC) prescription drug distribution proposals IPC is opposed to the HRSA 340B proposed rebate model IPC opposes HR 6509/S. 3794 Safe Drug Act of 2026. IPC opposes HR 5316 the \"Drug Shortage Compounding Patient Access Act of 2025\" IPC supports the Breakup Big Medicine Act S. 3822 IPC supports Protecting Pharmacies in Medicaid Act S. 927 IPC supports the US Department of Labor proposed rule on PBM transparency [RIN 1210-AB37]","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":21818,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"EUGENE","last_name":"KINNEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65102,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"A.","last_name":"COVELLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/62719e34-72d2-4ee6-8bbf-d4840708b637/","filing_uuid":"62719e34-72d2-4ee6-8bbf-d4840708b637","filing_type":"RR","filing_type_display":"Registration","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/62719e34-72d2-4ee6-8bbf-d4840708b637/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Joshua Andrews","dt_posted":"2026-07-16T17:37:47-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1500 K St NW","registrant_address_2":"Suite 1100","registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":12631,"url":"https://lda.gov/api/v1/registrants/12631/","house_registrant_id":31801,"name":"FAEGRE DRINKER BIDDLE & REATH LLP","description":"Law firm","address_1":"1500 K St NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ZOOK","contact_telephone":"+1 202-312-7414","dt_updated":"2026-07-30T11:30:36.878220-04:00"},"client":{"id":74109,"url":"https://lda.gov/api/v1/clients/74109/","client_id":74109,"name":"COLLABORATIVE FOR EVIDENCE-BASED MEDICINES","general_description":"Evidence-based medicines","client_government_entity":null,"client_self_select":false,"state":"IN","state_display":"Indiana","country":"US","country_display":"United States of America","ppb_state":"IN","ppb_state_display":"Indiana","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-07-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Drug compounding issues; SAFE Drugs Act (H.R. 6509 / S. 3794)","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":79338,"prefix":null,"prefix_display":null,"first_name":"JOSH","nickname":null,"middle_name":null,"last_name":"ANDREWS","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Rep. Anna G. Eshoo (CA-14); Legislative Correspondent, Sen. Barbara Boxer (D-CA)","new":true},{"lobbyist":{"id":154309,"prefix":null,"prefix_display":null,"first_name":"BARRETT","nickname":null,"middle_name":null,"last_name":"TENBARGE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d075f73d-3c52-4b81-9008-eb25c3786a4c/","filing_uuid":"d075f73d-3c52-4b81-9008-eb25c3786a4c","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/d075f73d-3c52-4b81-9008-eb25c3786a4c/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Megan Herber","dt_posted":"2026-07-20T10:48:36-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1500 K St NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":12631,"url":"https://lda.gov/api/v1/registrants/12631/","house_registrant_id":31801,"name":"FAEGRE DRINKER BIDDLE & REATH LLP","description":"Law firm","address_1":"1500 K St NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ZOOK","contact_telephone":"+1 202-312-7414","dt_updated":"2026-07-30T11:30:36.878220-04:00"},"client":{"id":204140,"url":"https://lda.gov/api/v1/clients/204140/","client_id":1006361,"name":"NATIONAL ASSOCIATION OF BOARDS OF PHARMACY","general_description":"Association of member boards of pharmacy to protect public health","client_government_entity":false,"client_self_select":null,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":79283,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":"SUSSMAN","last_name":"HERBER","suffix":null,"suffix_display":null},"covered_position":"Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA)","new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009-2010","new":false},{"lobbyist":{"id":143298,"prefix":null,"prefix_display":null,"first_name":"MAYA","nickname":null,"middle_name":null,"last_name":"BOLTER","suffix":null,"suffix_display":null},"covered_position":"Legislative Intern, Representative Dean Phillips (D-MN-03), September 2019-December 2019","new":false},{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":79283,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":"SUSSMAN","last_name":"HERBER","suffix":null,"suffix_display":null},"covered_position":"Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA)","new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009-2010","new":false},{"lobbyist":{"id":143298,"prefix":null,"prefix_display":null,"first_name":"MAYA","nickname":null,"middle_name":null,"last_name":"BOLTER","suffix":null,"suffix_display":null},"covered_position":"Legislative Intern, Representative Dean Phillips (D-MN-03), September 2010-December 2019","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/5aeed365-9cae-4c32-bca6-fbf2dc77d69d/","filing_uuid":"5aeed365-9cae-4c32-bca6-fbf2dc77d69d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/5aeed365-9cae-4c32-bca6-fbf2dc77d69d/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Elizabeth Baney","dt_posted":"2026-07-20T10:53:14-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1500 K Street NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":12631,"url":"https://lda.gov/api/v1/registrants/12631/","house_registrant_id":31801,"name":"FAEGRE DRINKER BIDDLE & REATH LLP","description":"Law firm","address_1":"1500 K St NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ZOOK","contact_telephone":"+1 202-312-7414","dt_updated":"2026-07-30T11:30:36.878220-04:00"},"client":{"id":204137,"url":"https://lda.gov/api/v1/clients/204137/","client_id":1006373,"name":"ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL)","general_description":"Coalition to ensure patient access to safe and legitimate online pharmacies","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/5aeed365-9cae-4c32-bca6-fbf2dc77d69d/","filing_uuid":"5aeed365-9cae-4c32-bca6-fbf2dc77d69d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/5aeed365-9cae-4c32-bca6-fbf2dc77d69d/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Elizabeth Baney","dt_posted":"2026-07-20T10:53:14-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1500 K Street NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":12631,"url":"https://lda.gov/api/v1/registrants/12631/","house_registrant_id":31801,"name":"FAEGRE DRINKER BIDDLE & REATH LLP","description":"Law firm","address_1":"1500 K St NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ZOOK","contact_telephone":"+1 202-312-7414","dt_updated":"2026-07-30T11:30:36.878220-04:00"},"client":{"id":204137,"url":"https://lda.gov/api/v1/clients/204137/","client_id":1006373,"name":"ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL)","general_description":"Coalition to ensure patient access to safe and legitimate online pharmacies","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/5aeed365-9cae-4c32-bca6-fbf2dc77d69d/","filing_uuid":"5aeed365-9cae-4c32-bca6-fbf2dc77d69d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/5aeed365-9cae-4c32-bca6-fbf2dc77d69d/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Elizabeth Baney","dt_posted":"2026-07-20T10:53:14-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1500 K Street NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":12631,"url":"https://lda.gov/api/v1/registrants/12631/","house_registrant_id":31801,"name":"FAEGRE DRINKER BIDDLE & REATH LLP","description":"Law firm","address_1":"1500 K St NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ZOOK","contact_telephone":"+1 202-312-7414","dt_updated":"2026-07-30T11:30:36.878220-04:00"},"client":{"id":204137,"url":"https://lda.gov/api/v1/clients/204137/","client_id":1006373,"name":"ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL)","general_description":"Coalition to ensure patient access to safe and legitimate online pharmacies","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/5aeed365-9cae-4c32-bca6-fbf2dc77d69d/","filing_uuid":"5aeed365-9cae-4c32-bca6-fbf2dc77d69d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/5aeed365-9cae-4c32-bca6-fbf2dc77d69d/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Elizabeth Baney","dt_posted":"2026-07-20T10:53:14-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1500 K Street NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":12631,"url":"https://lda.gov/api/v1/registrants/12631/","house_registrant_id":31801,"name":"FAEGRE DRINKER BIDDLE & REATH LLP","description":"Law firm","address_1":"1500 K St NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ZOOK","contact_telephone":"+1 202-312-7414","dt_updated":"2026-07-30T11:30:36.878220-04:00"},"client":{"id":204137,"url":"https://lda.gov/api/v1/clients/204137/","client_id":1006373,"name":"ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL)","general_description":"Coalition to ensure patient access to safe and legitimate online pharmacies","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/0b40eb79-fb41-4351-982f-6ad1e3f21942/","filing_uuid":"0b40eb79-fb41-4351-982f-6ad1e3f21942","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/0b40eb79-fb41-4351-982f-6ad1e3f21942/print/","filing_document_content_type":"text/html","income":null,"expenses":"220000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Amy Shank","dt_posted":"2026-07-20T14:33:46-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"9901 S. Wilcrest Dr","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Houston","registrant_state":"TX","registrant_zip":"77099","registrant":{"id":401103386,"url":"https://lda.gov/api/v1/registrants/401103386/","house_registrant_id":null,"name":"PROFESSIONAL COMPOUNDING CENTERS OF AMERICA","description":"Membership organization providing resources to independent compounding pharmacies","address_1":"9901 S. Wilcrest Dr","address_2":null,"address_3":null,"address_4":null,"city":"Houston","state":"TX","state_display":"Texas","zip":"77099","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"AMY SHANK","contact_telephone":"+1 202-412-0412","dt_updated":"2026-07-24T14:07:59.280567-04:00"},"client":{"id":198794,"url":"https://lda.gov/api/v1/clients/198794/","client_id":12,"name":"PROFESSIONAL COMPOUNDING CENTERS OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-07-21"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Agriculture appropriations spending bill; Department of Labor-Health and Human Services appropriations bill","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60863,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"SHANK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154528,"prefix":null,"prefix_display":null,"first_name":"CLAIRE","nickname":null,"middle_name":null,"last_name":"CASEY","suffix":null,"suffix_display":null},"covered_position":"Intern, Congressman Jim Himes - 9/21 - 12/21; Intern, House Appropriations Committee, Subcommittee on Homeland Security - 1/22 - 5/22; Intern, Senator Richard Blumenthal - 5/22 - 7/22; Intern, Congressman Jamie Raskin - 7/22 - 8/22","new":true}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to implementation of the Drug Quality and Security Act, issues related to animal drug compounding, issues relating to opioid safety; issues related to the pharmaceutical supply chain; issues related to drug shortages; H.R. 5316, the Drug Shortage Compounding Patient Access Act of 2025; S. 3794 / H.R. 6509, The Safe Drugs Act; S. 3788/ H.R. 8269 The Clear Labels Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60863,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"SHANK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154528,"prefix":null,"prefix_display":null,"first_name":"CLAIRE","nickname":null,"middle_name":null,"last_name":"CASEY","suffix":null,"suffix_display":null},"covered_position":"Intern, Congressman Jim Himes - 9/21 - 12/21; Intern, House Appropriations Committee, Subcommittee on Homeland Security - 1/22 - 5/22; Intern, Senator Richard Blumenthal - 5/22 - 7/22; Intern, Congressman Jamie Raskin - 7/22 - 8/22","new":true}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to Medicare coverage of compounded medications, Drug shortages and Medicare reimbursement for compounded medications, pharmacy direct and indirect remuneration fees","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60863,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"SHANK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154528,"prefix":null,"prefix_display":null,"first_name":"CLAIRE","nickname":null,"middle_name":null,"last_name":"CASEY","suffix":null,"suffix_display":null},"covered_position":"Intern, Congressman Jim Himes - 9/21 - 12/21; Intern, House Appropriations Committee, Subcommittee on Homeland Security - 1/22 - 5/22; Intern, Senator Richard Blumenthal - 5/22 - 7/22; Intern, Congressman Jamie Raskin - 7/22 - 8/22","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/80d72449-e0d9-4f60-913b-6858dbeeeed0/","filing_uuid":"80d72449-e0d9-4f60-913b-6858dbeeeed0","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/80d72449-e0d9-4f60-913b-6858dbeeeed0/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Zachary Williams","dt_posted":"2026-07-20T15:37:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"777 6th Street NW","registrant_address_2":"8th Floor","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":400976792,"url":"https://lda.gov/api/v1/registrants/400976792/","house_registrant_id":null,"name":"FORBES-TATE","description":"Government Relations Firm.","address_1":"777 6th Street NW","address_2":"8th Floor","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ZACHARY WILLIAMS","contact_telephone":"+1 202-638-0125","dt_updated":"2026-07-20T16:54:02.529740-04:00"},"client":{"id":205133,"url":"https://lda.gov/api/v1/clients/205133/","client_id":1573,"name":"ELI LILLY AND COMPANY FKA LILLY USA, LLC","general_description":"Pharmaceutical Company","client_government_entity":false,"client_self_select":null,"state":"IN","state_display":"Indiana","country":"US","country_display":"United States of America","ppb_state":"IN","ppb_state_display":"Indiana","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to the report accompanying the FY 26 Senate Labor-HHS-Education Appropriations; Issues related to Rx drug pricing in the One Big Beautiful Bill Act (P.L. 119-21).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/80d72449-e0d9-4f60-913b-6858dbeeeed0/","filing_uuid":"80d72449-e0d9-4f60-913b-6858dbeeeed0","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/80d72449-e0d9-4f60-913b-6858dbeeeed0/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Zachary Williams","dt_posted":"2026-07-20T15:37:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"777 6th Street NW","registrant_address_2":"8th Floor","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":400976792,"url":"https://lda.gov/api/v1/registrants/400976792/","house_registrant_id":null,"name":"FORBES-TATE","description":"Government Relations Firm.","address_1":"777 6th Street NW","address_2":"8th Floor","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ZACHARY WILLIAMS","contact_telephone":"+1 202-638-0125","dt_updated":"2026-07-20T16:54:02.529740-04:00"},"client":{"id":205133,"url":"https://lda.gov/api/v1/clients/205133/","client_id":1573,"name":"ELI LILLY AND COMPANY FKA LILLY USA, LLC","general_description":"Pharmaceutical Company","client_government_entity":false,"client_self_select":null,"state":"IN","state_display":"Indiana","country":"US","country_display":"United States of America","ppb_state":"IN","ppb_state_display":"Indiana","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to the report accompanying the FY 26 Senate Labor-HHS-Education Appropriations; Issues related to Rx drug pricing in the One Big Beautiful Bill Act (P.L. 119-21).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/87460353-a57a-415e-87e1-53040d845fc6/","filing_uuid":"87460353-a57a-415e-87e1-53040d845fc6","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/87460353-a57a-415e-87e1-53040d845fc6/print/","filing_document_content_type":"text/html","income":null,"expenses":"30000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Mark Kinney","dt_posted":"2026-10-08T10:03:41-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1550 Columbus Street","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Sun Prairie","registrant_state":"WI","registrant_zip":"53590","registrant":{"id":313098,"url":"https://lda.gov/api/v1/registrants/313098/","house_registrant_id":39121,"name":"INDEPENDENT PHARMACY COOPERATIVE","description":null,"address_1":"1550 Columbus Street","address_2":null,"address_3":null,"address_4":null,"city":"Sun Prairie","state":"WI","state_display":"Wisconsin","zip":"53590","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MR. MARK KINNEY","contact_telephone":"+1 608-628-7311","dt_updated":"2026-07-14T13:14:46.836994-04:00"},"client":{"id":184073,"url":"https://lda.gov/api/v1/clients/184073/","client_id":12,"name":"INDEPENDENT PHARMACY COOPERATIVE","general_description":"National GPO and drug distribution services for independent pharmacies.","client_government_entity":false,"client_self_select":true,"state":"WI","state_display":"Wisconsin","country":"US","country_display":"United States of America","ppb_state":"WI","ppb_state_display":"Wisconsin","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-07-16"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"IPC supports S. 526 Pharmacy Benefit Manager Transparency Act of 2025 IPC supports S. 527 \"Prescription Pricing for People Act of 2025 IPC supports H.R. 4317/S.3345 PBM Reform Act of 2025 IPC supports H.R. 3164/S. 2426 - \"Main Street Pharmacy Access Act\" IPC supports H.R. 6609 & H.R. 6610 - Pharmacists Fights Back Act IPC supports H.R. 5256 340B Affording Care for Communities and Ensuring a Strong Safety-Net Act (340B ACCESS Act) IPC monitors Trump Administration 340B Rebate Pilot Program adoption and implementation IPC supports OBBBA - Rural Health Transformation Program - grant implementation IPC monitors Senate BI-Partisan 340B working group - draft legislation IPC monitors Trump Administration overseas manufactured drug Section 232 tariffs investigation IPC monitors Trump Administration Drug Pricing Most Favored Nations status/Direct to Consumer (DTC) prescription drug distribution proposals IPC monitors HR 879/S.3794 Safe Drug Act of 2026 IPC is opposed to the HRSA 340B proposed rebate model IPC opposes HR 6509/S. 3794 Safe Drug Act of 2026. IPC opposes HR 5316 the \"Drug Shortage Compounding Patient Access Act of 2025\" IPC supports the Breakup Big Medicine Act S. 3822 IPC supports Protecting Pharmacies in Medicaid Act S. 927 IPC supports the US Department of Labor proposed rule on PBM transparency [RIN 1210-AB37]","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":21818,"prefix":"mr","prefix_display":"MR.","first_name":"MARK","nickname":null,"middle_name":"EUGENE","last_name":"KINNEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65102,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":"A.","last_name":"COVELLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/6fe909bc-3b9b-479b-b765-bbbc1b0ed024/","filing_uuid":"6fe909bc-3b9b-479b-b765-bbbc1b0ed024","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/6fe909bc-3b9b-479b-b765-bbbc1b0ed024/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Zachary Williams","dt_posted":"2026-10-19T22:42:11-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"777 6th Street NW","registrant_address_2":"8th Floor","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":400976792,"url":"https://lda.gov/api/v1/registrants/400976792/","house_registrant_id":null,"name":"FORBES-TATE","description":"Government Relations Firm.","address_1":"777 6th Street NW","address_2":"8th Floor","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ZACHARY WILLIAMS","contact_telephone":"+1 202-638-0125","dt_updated":"2026-07-20T16:54:02.529740-04:00"},"client":{"id":205133,"url":"https://lda.gov/api/v1/clients/205133/","client_id":1573,"name":"ELI LILLY AND COMPANY FKA LILLY USA, LLC","general_description":"Pharmaceutical Company","client_government_entity":false,"client_self_select":null,"state":"IN","state_display":"Indiana","country":"US","country_display":"United States of America","ppb_state":"IN","ppb_state_display":"Indiana","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to the report accompanying the FY 26 Senate Labor-HHS-Education Appropriations; Issues related to Rx drug pricing in the One Big Beautiful Bill Act (PL 119-21).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/6fe909bc-3b9b-479b-b765-bbbc1b0ed024/","filing_uuid":"6fe909bc-3b9b-479b-b765-bbbc1b0ed024","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/6fe909bc-3b9b-479b-b765-bbbc1b0ed024/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Zachary Williams","dt_posted":"2026-10-19T22:42:11-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"777 6th Street NW","registrant_address_2":"8th Floor","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":400976792,"url":"https://lda.gov/api/v1/registrants/400976792/","house_registrant_id":null,"name":"FORBES-TATE","description":"Government Relations Firm.","address_1":"777 6th Street NW","address_2":"8th Floor","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ZACHARY WILLIAMS","contact_telephone":"+1 202-638-0125","dt_updated":"2026-07-20T16:54:02.529740-04:00"},"client":{"id":205133,"url":"https://lda.gov/api/v1/clients/205133/","client_id":1573,"name":"ELI LILLY AND COMPANY FKA LILLY USA, LLC","general_description":"Pharmaceutical Company","client_government_entity":false,"client_self_select":null,"state":"IN","state_display":"Indiana","country":"US","country_display":"United States of America","ppb_state":"IN","ppb_state_display":"Indiana","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025; Issues related to S. 3794 - SAFE Drugs Act of 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to the report accompanying the FY 26 Senate Labor-HHS-Education Appropriations; Issues related to Rx drug pricing in the One Big Beautiful Bill Act (PL 119-21).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68997,"prefix":null,"prefix_display":null,"first_name":"CYNTHIA","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57902,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"GREER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70162,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"DUNKLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138827,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ALEXANDER","last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/5028fdef-bf7e-4506-85e9-463dc426e00a/","filing_uuid":"5028fdef-bf7e-4506-85e9-463dc426e00a","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/5028fdef-bf7e-4506-85e9-463dc426e00a/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Solveig L Monson","dt_posted":"2026-10-20T08:54:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1341 G Street, NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":284950,"url":"https://lda.gov/api/v1/registrants/284950/","house_registrant_id":36893,"name":"MEHLMAN CONSULTING, INC.","description":"Government Affairs Consulting Services","address_1":"1341 G Street, NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SOLVEIG MONSON","contact_telephone":"+1 202-585-0292","dt_updated":"2026-10-20T18:04:37.956203-04:00"},"client":{"id":68552,"url":"https://lda.gov/api/v1/clients/68552/","client_id":68552,"name":"BETTER LIFE HEALTH, INC.","general_description":"Weight loss telehealth platform","client_government_entity":null,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-08-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to compounding pharmacies. S. 3794 - SAFE Drugs Act of 2025.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155107,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"BRADY","suffix":null,"suffix_display":null},"covered_position":"Dir Leg Affairs (DOC, Intl Trade Admin); CoS, Dep. CoS/ LD, SLA, LA, Staff Asst (Rep. Vern Buchanan); Intern (Rep. Fred Upton); Intern (Rep. Dan Lungren)","new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/157cb709-23d0-4227-8006-c6a780885f8e/","filing_uuid":"157cb709-23d0-4227-8006-c6a780885f8e","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/157cb709-23d0-4227-8006-c6a780885f8e/print/","filing_document_content_type":"text/html","income":"70000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Elizabeth Baney","dt_posted":"2026-10-20T11:19:47-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1500 K Street NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":12631,"url":"https://lda.gov/api/v1/registrants/12631/","house_registrant_id":31801,"name":"FAEGRE DRINKER BIDDLE & REATH LLP","description":"Law firm","address_1":"1500 K St NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ZOOK","contact_telephone":"+1 202-312-7414","dt_updated":"2026-07-30T11:30:36.878220-04:00"},"client":{"id":204137,"url":"https://lda.gov/api/v1/clients/204137/","client_id":1006373,"name":"ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL)","general_description":"Coalition to ensure patient access to safe and legitimate online pharmacies","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/157cb709-23d0-4227-8006-c6a780885f8e/","filing_uuid":"157cb709-23d0-4227-8006-c6a780885f8e","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/157cb709-23d0-4227-8006-c6a780885f8e/print/","filing_document_content_type":"text/html","income":"70000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Elizabeth Baney","dt_posted":"2026-10-20T11:19:47-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1500 K Street NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":12631,"url":"https://lda.gov/api/v1/registrants/12631/","house_registrant_id":31801,"name":"FAEGRE DRINKER BIDDLE & REATH LLP","description":"Law firm","address_1":"1500 K St NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ZOOK","contact_telephone":"+1 202-312-7414","dt_updated":"2026-07-30T11:30:36.878220-04:00"},"client":{"id":204137,"url":"https://lda.gov/api/v1/clients/204137/","client_id":1006373,"name":"ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL)","general_description":"Coalition to ensure patient access to safe and legitimate online pharmacies","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/157cb709-23d0-4227-8006-c6a780885f8e/","filing_uuid":"157cb709-23d0-4227-8006-c6a780885f8e","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/157cb709-23d0-4227-8006-c6a780885f8e/print/","filing_document_content_type":"text/html","income":"70000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Elizabeth Baney","dt_posted":"2026-10-20T11:19:47-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1500 K Street NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":12631,"url":"https://lda.gov/api/v1/registrants/12631/","house_registrant_id":31801,"name":"FAEGRE DRINKER BIDDLE & REATH LLP","description":"Law firm","address_1":"1500 K St NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ZOOK","contact_telephone":"+1 202-312-7414","dt_updated":"2026-07-30T11:30:36.878220-04:00"},"client":{"id":204137,"url":"https://lda.gov/api/v1/clients/204137/","client_id":1006373,"name":"ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL)","general_description":"Coalition to ensure patient access to safe and legitimate online pharmacies","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Illicit prescription drug sales online; Rogue internet drug sellers; Drug supply chain security; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Social media and online marketplace platform accountability; FDA Destruction Authority; SAFE Drugs Act (H.R. 6509, S. 3794).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152887,"prefix":"ms","prefix_display":"MS.","first_name":"LIBBY","nickname":null,"middle_name":null,"last_name":"BANEY BURSTEIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82883,"prefix":null,"prefix_display":null,"first_name":"NISHA","nickname":null,"middle_name":null,"last_name":"QUASBA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138146,"prefix":"mr","prefix_display":"MR.","first_name":"ELLIOT","nickname":null,"middle_name":null,"last_name":"VICE","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent & Scheduler, Senator Evan Bayh (D-IN) 2009 - 2010","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}